Search PubMed⌕ Search

Biomedical subjects

M Kriegerowski

Publications and source records attributed to M Kriegerowski.

11 recordsLinked to original sources

Mesopic vision in myopia corrected by photorefractive keratectomy, soft contact lenses, and spectacles.

PURPOSE: To evaluate contrast vision and glare sensitivity under mesopic conditions in eyes having uncomplicated excimer laser photorefractive keratectomy (PRK) for myopia and in eyes corrected by disposable soft contact lenses, soft contact lenses, and spectacles. SETTING: Division of Experimental Ophthalmic Surgery, University of Tübingen, Germany. METHODS: The Mesoptometer II test was used to evaluate mesopic vision (glare sensitivity and contrast vision) in 28 eyes of 14 patients wearing disposable soft contact lenses, 20 eyes of 10 patients wearing soft contact lenses, 39 eyes of 20 patients wearing spectacles, 30 eyes of 15 emmetropic patients, and 33 eyes of 22 patients after PRK with 5.0 mm optical zone. Follow-up was between 15 and 60 months after PRK (mean 34.5 months). RESULTS: The guidelines of the German Ophthalmologic Society state that patients must recognize Mesoptometer II contrast levels of 1:5 or better with and without glare to meet the minimum legal night-driving standards for private cars. All eyes with disposable soft contact lenses and soft contact lenses, all emmetropic eyes, and 38 eyes corrected by spectacles recognized contrast levels of 1:5 or better without glare. In contrast, 18 eyes in the PRK group were unable to recognize contrast level 1:5 without glare. With glare, 1 eye in the disposable soft contact lens group, 1 in the soft contact lens group, and 7 with spectacles were unable to recognize the 1:5 contrast level. All emmetropic eyes recognized contrast levels of 1:5 or better; 22 PRK eyes were unable to recognize contrast level 1:5 with glare. CONCLUSION: Myopic PRK may lead to long-term impairment of mesopic vision, while soft contact lens use does not seem to markedly influence mesopic vision in eyes with low to moderate myopia.

Adolescent↗

[Massive foreign body reaction after intraocular penetration of hot, liquid plastic].

PATIENT: A 32-year-old male had an injury of his right eye by hot liquid plastic (Ultradur R). Intraoperatively, the eye was found broadly penetrated and filled up by more than 50% with ragged pieces of plastic. Computed tomography three days after wound closure revealed remaining foreign body material. As function was totally lost no further operation was considered. Seven weeks after the trauma, the eye was enucleated because of a painful phthisis. Histology showed numerous giant cells. CONCLUSIONS: Hot liquid plastic may perforate the eye and fill it up to a great extent. Due to intraocular cooling, pieces with sharp edges may develop, thus producing further (mechanical) tissue damage. Intraocular plastic is able to induce a massive foreign body reaction. It may be detected easily by computed tomography.

Adult↗

[Effectiveness of dorzolamide as added therapy in glaucoma patients with maximum tolerated drug therapy. A pilot study].

BACKGROUND: The purpose of this study was to evaluate prospectively the value of dorzolamid as an adjunct to maximum tolerated medical therapy in glaucoma patients in whom surgery would otherwise be required. METHODS: 32 eyes of 21 patients with primary open angle glaucoma (14 patients), glaucoma in aphakia (3 patients), pigmentary glaucoma (2 patients), juvenile glaucoma (1 patient) and exfoliative glaucoma (1 patient) were included. The effect of additional dorzolamid application on intraocular pressure (IOP) was determined after 2 hours, 4 days, 4 weeks, 3 months and 6 months. After 6 months, visual fields were checked. RESULTS: Average reduction of IOP in eyes in which dorzolamid was continued was determined to be 31% after 2 hours, 18.3% after 4 days, 17.9% after 4 weeks, 12.1% after 3 months and 9.7% after 6 months. 19 (59%) eyes continued to receive dorzolamid after 6 months without being operated. No progression of glaucomatous damage could be detected in these eyes. In 11 (34%) eyes, treatment with dorzolamid was discontinued. 2 patients (4 (12%) eyes) did not tolerate local side effects of dorzolamid. In 7 (22%) eyes reduction of IOP was insufficient and filtration surgery had to be performed immediately. CONCLUSION: The results of the present study demonstrate that dorzolamid represents an alternative to an immediate surgical management in patients on maximum tolerated therapy for at least six months.

Adult↗

[Diode laser cyclophotocoagulation in treatment of therapy refractory glaucoma].

BACKGROUND: It has been suggested that Nd:YAG laser cyclophotocoagulation significantly lowers the intraocular pressure in refractory glaucoma. However, only limited information is currently available concerning the cyclodestructive effects of diode laser cyclophotocoagulation. PATIENTS AND METHODS: Twenty eyes of 17 patients had undergone diode laser cyclophotocoagulation if previous glaucoma surgery including cyclocryocoagulation was unsuccessful or the patients were blind. Nine eyes had secondary glaucoma, 5 neovascular glaucoma, 5 congenital glaucoma, and 1 eye chronic open angle glaucoma. Treatment was applied in two quadrants using a 810 nm diode laser (600 qm diameter quartz fiber, 2 sec, 1.75-3 W, 6 to 10 pulses). Seven eyes required retreatment. RESULTS: In 19 eyes the baseline IOP was 32.1 +/- 10.1 mm Hg and at the patient's last examination 21.0 +/- 8.4 mm Hg. Median follow up was 11 months (3 to 19 months). In 4 of 5 eyes with a visual acuity of less than 1/50 IOP was decreased under 30 mm Hg, while 9 of 14 eyes with a visual acuity of at least 1/50 IOP revealed a decrease of IOP under 20 mm Hg, resulting in a success rate of 68%. Complications included acute severe anterior uveitis in one eye and bulbus hypotonia in another for several months. After three weeks, one eye was enucleated because of persisting high IOP and pain. Histopathologically, coagulation necrosis of the ciliary body stroma and separation of epithelial layers were observed. CONCLUSIONS: This study suggests that contact diode laser cyclophotocoagulation is an effective method and a valid alternative to cyclocryocoagulation in the treatment of refractory glaucoma including congenital glaucoma.

Adolescent↗

[Excimer laser keratomileusis for myopia correction. Results and complications].

Results of excimer laser keratomileusis in 26 myopic sighted eyes are presented. The follow-up was at least 9 months. The base-line refraction was -4.48 +/- 1.81 D (range: -1.4 to -9.25 D). After 3 months 85% were within +/- 1 D from the intended refraction. The such defined success rate after 6 months was 87.5%, after 9 months 88%, and after 12 months 92%. One month after surgery we found an overcorrection of +1.45 +/- 1.22 D decreasing to +0.27 +/- 0.94 D at three months, becoming an undercorrection of -0.24 +/- 0.76 D after six, and -0.32 +/- 0.69 D after nine months, and of -0.36 +/- 0.6 D after one year. Stability within the measurement error (+/- 0.25 D) appeared in 79% of the treated eyes six months after treatment. Three patients have been excluded from the study group because they did not follow the protocol. Subepithelial haze occurred in all patients, becoming most intense after 3 months, gradually clearing over the next months. With appropriate steroid medication, the refractive effect may be modulated. Complications as steroid glaucoma, recurrent erosion, loss of acuity, or extensive corneal scarring seem to be very rare.

Adult↗

[Laser keratomileusis for correction of myopia].

Laser keratomileusis with the excimer laser (193 nm) is a new method of refractive surgery. With this procedure a thin lenticule is ablated from the central cornea with submicron precision. The refraction changes achieved in 13 eyes ranged from 1.5 to 7.5 dpt. With this correction 92% of the treated eyes were within 1.0 dpt either way at 3 months after surgery, but after 6 months this proportion decreased to 77%. The best-corrected visual acuity recovers within 1 months to preoperative values. In all patients a slight subepithelial haze was detected with the slit-lamp in the early postoperative phase, but cleared within 4-6 months to a clinically non-significant level.

Adult↗

[The ablation behavior of various corneal layers].

The difference in structure of the corneal layers leads to an inhomogeneous reaction to photoablation with 193 nm excimer laser light. This is important for the calculation of photorefractive keratectomy (PRK) where only a thin layer (10-50 microns) of the cornea must be removed. Therefore, the ablation rate for the Bowman zone is 2.5 times lower than that for corneal stroma; the same value is found in Descemet membrane. In contrast, the ablation rate of the epithelium is 1.5 times higher. Based on these data it will be possible to achieve high precision with PRK.

Astigmatism↗

[Partial external trabeculectomy].

The authors show that with the Excimer laser partial trabeculectomy can be performed, a procedure in which the juxtacanalicular meshwork is removed while the other layers remain untouched. It was proved in experiments on ten enucleated human eyes that at most 3% of the outflow resistance is localized in the uveal and sclerocorneal meshwork. The clinical applicability of partial trabeculectomy was demonstrated on five eyes.

Choroid Neoplasms↗

Ablation rate of human corneal epithelium and Bowman's layer with the excimer laser (193 nm).

Laser keratomileusis is a laser-specific procedure whereby a layer of corneal tissue as thin as 10 microns or more is removed from the anterior surface. In most cases, the laser ablates not only Bowman's layer but also portions of the anterior stroma. The histologic evaluation presented shows that the ablation behavior of these two layers is not uniform: at a fluence of 205 mJ/cm2 in Bowman's layer, the ablation rate was 0.38 +/- 0.05 microns per pulse, whereas in stroma it amounted to 0.55 +/- 0.1 microns per pulse. In epithelium, the ablation rate was 0.68 +/- 0.15 microns per pulse, but decreased with deeper excisions. We discuss the consequences of these different ablation rates on the procedure of laser keratomileusis.

Cornea↗

Excimer laser (193 nm) myopic keratomileusis in sighted and blind human eyes.

Ten blind and 13 sighted human eyes underwent excimer laser (193 nm) keratomileusis. The radiant exposure was 180 mJ/cm2 with an ablation zone diameter of 3.5 mm. The follow-up of the blind eyes ranged from 9 to 11 months, whereas that of the sighted eyes was at least 6 months. The intended refraction change was -3.0 and -5.0 D in the blind eyes and ranged from -1.5 to -7.0 D in the sighted eyes. After 3 months, 12 of 13 sighted eyes (92%) achieved a refraction between +/- 1.0 D, whereas after 6 months 77% of the refractions were in this range. Temporary subepithelial haze occurred in all eyes except some of the -3.0 D blind eyes. After 6 months, the subepithelial haze had resolved to a clinical non-significant level (trace to grade 0.5 haze), except in one eye that showed a focal scar.

Adult↗